Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Insider Sells 4,900 Shares of Stock

Key Points

• Insider Transaction: Scott Moomaw, an insider at Liquidia Technologies (NASDAQ:LQDA), sold 4,900 shares at an average price of $23.41, totaling approximately $114,709, reducing his ownership by 3.09%.
• Stock Performance: Liquidia Technologies' stock rose by 1.7% to $23.16, with recent trading volumes exceeding its average, and the company has a current market cap of $1.99 billion.
• Earnings Report: The company reported a negative EPS of ($0.49) for the last quarter, missing estimates, but achieved a 141.5% year-over-year revenue increase to $8.84 million.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Scott Moomaw sold 4,900 shares of Liquidia Technologies stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $23.41, for a total value of $114,709.00. Following the sale, the insider directly owned 153,462 shares of the company's stock, valued at approximately $3,592,545.42. This trade represents a 3.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Liquidia Technologies Stock Up 1.7%

LQDA stock traded up $0.39 during midday trading on Wednesday, hitting $23.16. The company's stock had a trading volume of 1,994,182 shares, compared to its average volume of 1,944,347. The firm's 50-day moving average is $25.00 and its 200-day moving average is $18.47. The company has a market cap of $1.99 billion, a PE ratio of -13.62 and a beta of 0.15. The company has a current ratio of 2.49, a quick ratio of 2.41 and a debt-to-equity ratio of 9.84. Liquidia Technologies, Inc. has a 12 month low of $9.71 and a 12 month high of $29.94.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The firm had revenue of $8.84 million for the quarter, compared to the consensus estimate of $3.90 million. The company's quarterly revenue was up 141.5% on a year-over-year basis. On average, equities research analysts forecast that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. Raymond James Financial boosted their target price on shares of Liquidia Technologies from $33.00 to $41.00 and gave the stock a "strong-buy" rating in a research note on Wednesday, August 13th. Jefferies Financial Group assumed coverage on Liquidia Technologies in a report on Friday, August 15th. They issued a "buy" rating and a $43.00 price objective on the stock. Needham & Company LLC lifted their price target on shares of Liquidia Technologies from $32.00 to $36.00 and gave the stock a "buy" rating in a research note on Tuesday, August 12th. Wells Fargo & Company lifted their target price on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a report on Wednesday, August 13th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $35.00 price target on shares of Liquidia Technologies in a report on Monday, October 6th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $32.38.

Institutional Trading of Liquidia Technologies

Institutional investors and hedge funds have recently modified their holdings of the business. NewEdge Advisors LLC bought a new position in Liquidia Technologies in the 2nd quarter valued at about $25,000. Hurley Capital LLC bought a new position in shares of Liquidia Technologies during the 1st quarter valued at about $32,000. GAMMA Investing LLC lifted its stake in Liquidia Technologies by 65.6% during the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after buying an additional 1,173 shares in the last quarter. Quarry LP purchased a new position in shares of Liquidia Technologies in the first quarter worth approximately $79,000. Finally, Steward Partners Investment Advisory LLC raised its holdings in shares of Liquidia Technologies by 24.0% during the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock valued at $77,000 after acquiring an additional 1,200 shares during the period. 64.54% of the stock is owned by institutional investors and hedge funds.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.